Understanding how CELF1 contributes to Myotonic Dystrophy Type 1
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
This study is looking at a protein called CELF1 that is linked to muscle weakness in people with Myotonic Dystrophy Type 1, using special mice to learn how it affects muscle function, which could help find new ways to treat the condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10996098 on NIH RePORTER |
What this research studies
This research investigates the role of CELF1, a protein that is upregulated in Myotonic Dystrophy Type 1 (DM1), and how it contributes to the muscle weakness and wasting associated with the condition. By studying genetically modified mice that mimic adult-onset DM1, researchers aim to uncover the mechanisms behind CELF1's upregulation and its effects on muscle function. The approach involves analyzing changes in RNA splicing and protein levels in skeletal muscle, which could provide insights into potential therapeutic targets for DM1. Patients may benefit from a better understanding of the disease's pathology and the development of new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are adults diagnosed with Myotonic Dystrophy Type 1.
Not a fit: Patients with other forms of muscular dystrophy or those without a diagnosis of Myotonic Dystrophy Type 1 may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches for treating Myotonic Dystrophy Type 1.
How similar studies have performed: Previous research has shown success in understanding RNA-binding proteins in muscular dystrophies, but the specific role of CELF1 in DM1 is still being explored.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Nitschke, Larissa — Baylor College of Medicine
- Study coordinator: Nitschke, Larissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.